DECENTRALIZED TRIAL (DCT) TECHNOLOGY INSIGHTS
-
Tufts & PACT Release New DCT Analysis
We take a closer look at some of the key stats in a new DCT report from the Partnership for Advancing Clinical Trials (PACT), a consortium hosted and facilitated by the Tufts Center for the Study of Drug Development (CSDD).
-
Not What I Expected From A Vendor Conference
Dan Schell recounts some of his key takeaways after attending the Veeva R&D Quality Summit in Boston in September 2024. Some of the topics discussed include DCTs, eCOA, and the need to simplify tech integration at sites.
DCT TECHNOLOGY RESOURCES
-
If remote visits are planned in both decentralized and hybrid trials, how precisely do the televisits work and how beneficial can this really be to study patients, site staff, and sponsors?
-
Dive into the prediction that the rapid adoption of eCOAs will continue to grow in 2022, as sponsors acknowledge how useful these tools have become in decentralized clinical trial (DCT) settings.
-
Remote cardiac monitoring technology is enabling the pharmaceutical industry to shift towards innovative, efficient, and patient-friendly clinical trials.
-
Depending on the level of decentralization of your trial, you need secure cloud-based technology to adhere to Good Clinical Practices (GCP) while overseeing, communicating, and managing the entire trial process. Read how the best tools are scalable to any level of enterprise complexity and help maintain study quality, while allowing you to adapt to any level of decentralization according to protocol.
-
Digital health technologies are transforming clinical trials through decentralization, improved data, and patient-centric approaches, driving efficiency and accessibility.
-
Learn how mobile technology can promote trial inclusivity and diversity, and its potential to revolutionize clinical studies, making them more accessible and representative of the population.
-
DCTs, RWD, IRA … our industry predictions for 2024 are filled with acronyms. As we delve into 2024, explore what trends are hot ― and not ― for the coming year, and their impact on the industry.